Hospital transfer for primary coronary angioplasty in high risk patients with acute myocardial infarction

Heart

Volumn 82, Issue 4, 1999, Pages 415-419

  Straumann, E ^a   Yoon, S ^a   Naegeli, B ^a   Frielingsdorf, J ^a   Gerber, A ^a   Schuiki, E ^a   Bertel, O ^a  

^a TRIEMLI HOSPITAL   (Switzerland)

Author keywords

Acute myocardial infarction; Hospital transfer; Primary percutaneous transluminal coronary angioplasty; Time delay

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INTERHOSPITAL COOPERATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESUSCITATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0032852885     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.82.4.415     Document Type: Article

References (21)

1. 1 Weaver WD, Simes J, Betriu A, et al. Comparison of primary coronary angioplasty and thrombolytic therapy for acute myocardial infarction. JAMA 1997;278:2093-8.
2. 2 Grines CL, Browne KF, Marco J, et al, for the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;329:673-82.
3. 3 GUSTO IIb Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997;336:1621-8.
4. 4 Zijlstra F, de Boer MJ, Hoorntje JCA, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
5. 5 GUSTO I Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22.
6. 6 Cannon CP, McCabe CH, Gibson CM, et al. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 10: dose-ranging trial. Circulation 1997;95:351-6.
7. 7 Bode C, Smalling RW, Berg G, et al. Randomised comparison of coronary thrombolysis achieved with double blind bolus reteplase (recombinant plasminogen activator) and front loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction: the RAPID II investigators. Circulation 1996;94: 891-8.
8. 8 Bellinger RL, Califf RM, Mark DB, et al. Helicopter transport of patients during acute myocardial infarction. Am J Cardiol 1988;61:718-22.
9. 9 Tiefenbrun AJ, Chandra NC, Every NR, et al. High mortality in patients with myocardial infarction transferred for primary angioplasty: a report from the national registry of myocardial infarction 2 [abstract]. Circulation 1997; 96(suppl):A351.
10. 10 GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
11. 11 Gruppo italiano per lo studio della streptochinasi nell'infarto miocardio (GISSI). Effectiveness of intravenous thrombolytic therapy in acute myocardial infarction. Lancet 1986;i:397-401.
12. 12 ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: second international study group of infarct survival (ISIS-2). Lancet 1988;ii:349-360.
13. 13 Simes RJ, Topol EJ, Homes DR Jr, et al. Link between the angiographic substudy and mortality in a large randomized trial of myocardial reperfusion: importance of early and complete infarct artery reperfusion. GUSTO-I investigators. Circulation 1995;91:1923-8.
14. 14 Zijlstra F, van't Hof AWJ, Liem AL, et al. Transferring patients for primary angioplasty: a retrospective analysis of 104 selected high risk patients with acute myocardial infarction. Heart 1997;78:333-6.
15. 15 Widimsky P, Groh L, Aschermann M, et al. Transport for primary PTCA: results of the pilot phase of the "PRAGUE" study - a national multicenter randomized study on patients with acute myocardial infarction presenting to community hospitals. Circulation 1998;98(suppl):I-771.
16. 16 Neumann FJ, Walter H, Richardt G, et al. Coronary Palmaz-Schatz stent implantation in acute myocardial infarction. Heart 1996;75:121-6.
17. 17 Antoniucci D, Valenti R, Santorno GM, et al. Systematic direct angioplasty and stem-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol 1998;31:294-300.
18. 18 Lefkuvits J, Ivanhoc RJ, Califf RM, et al for the EPIC investigators. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1996;77:1045-51.
19. 19 Kovack PJ, Rasak MA, Bates ER, et al. Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol 1997;29:1454-8.
20. 20 Ohman EM, George BS, White CJ, et al for the randomized IABP study group. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction: results of a randomized trial. Circulation 1994;90:792-9.
21. 21 Serruys PW, Kay IP. Cardiogenic shock: a failure in reperfusion. Time for a strategic chance? Eur Heart J 1999; 20:88-9.